Compounds > thiazoles
Page last updated: 2024-08-21

thiazoles and Bone Cancer

thiazoles has been researched along with Bone Cancer in 43 studies

Research

Studies (43)

TimeframeStudies, this research(%)All Research%
pre-19901 (2.33)18.7374
1990's2 (4.65)18.2507
2000's13 (30.23)29.6817
2010's25 (58.14)24.3611
2020's2 (4.65)2.80

Authors

AuthorsStudies
Dai, G; Liu, G; Song, Q; Zheng, D1
Cerra, C; Harris, MA; Hawkins, CJ; Miles, MA; Shekhar, TM1
Rahimnejad Yazdi, A; Torkan, L; Towler, MR; Waldman, SD1
Dai, G; Deng, S; Gao, T; Guo, W; Yang, J; Yu, L; Zhou, S1
Chen, Y; Guo, R; He, Q; Li, Y; Zhang, K; Zhong, G1
Bacon, NJ; Fahey, CE; Kow, K; Milner, RJ; Salute, ME1
Abraham, J; Bracha, S; Davis, LE; Helfand, SC; Hofmann, NE; Huang, ET; Keller, C; Li, G; Loriaux, MM; Mansoor, A; Marley, K; Mata, JE; Séguin, B; Tyner, JW1
Carlton, MM; Dirksen, WP; Hildreth, BE; Lanigan, LG; London, CA; Martin, CK; Pillai, SP; Rosol, TJ; Simmons, JK; Toribio, RE; Werbeck, JL1
Bovée, JV; Briaire-de Bruijn, IH; Gelderblom, H; Herpers, B; van de Water, B; van Oosterwijk, JG; van Ruler, MA1
Battaglia, S; Blanchard, F; Charrier, C; Gobin, B; Heymann, D; Huin, MB; Lamoureux, F; Lanel, R; Lezot, F; Ory, B; Redini, F1
Alumkal, JJ; Chin, BB; Deng, X; Doot, RK; Duan, F; Febbo, PG; Hartfeil, D; Herman, B; Higano, CS; Mankoff, DA; Muzi, M; Taplin, ME; Taub, JM; Yu, EY1
Arlt, MJ; Arras, M; Born, W; Fuchs, B; Husmann, K; Jirkof, P1
Ballazhi, L; Ibrahimi, I; Imeri, F; Jashari, A; Mikhova, B; Mladenovska, K; Popovski, E1
Beck, JF; Becker, S; Blümel, L; Blumrich, A; Focke, K; Grauel, D; Hentschel, J; Krämer, OH; Marx, C; Schinkel, S; Sonnemann, J; Wittig, S1
Aonuma, M; Fukutake, S; Kawato, H; Kitagawa, M; Miyazaki, M; Naito, H; Okayama, T; Seki, T; Soga, T; Sugimoto, Y; Uoto, K; Yoshida, K1
Gandour-Edwards, R; Holt, R; Rebhun, RB; Shahi, MH; Withers, SS; York, D1
Dringen, R; Rezwan, K; Shahabi, S; Treccani, L1
Ammendola, M; De Sarro, G; Gadaleta, CD; Leporini, C; Marech, I; Oakley, C; Ranieri, G; Russo, E; Sacco, R; Sammarco, G1
Gupte, A; Hawkins, CJ; Miles, MA; Shekhar, TM; Tascone, B; Taylor, S; Walkley, CR1
Bonnelye, E; Clézardin, P; Le Gall, C1
Saad, F1
Brown, LG; Corey, E; Koreckij, T; Nguyen, H; Vessella, RL; Yu, EY1
Chen, JT; Chen, Q; Deng, YJ; Shi, ZJ; Zhang, JH1
Araujo, JC; Corn, P; Darnay, BG; Lee, F; Logothetis, CJ; Parikh, NU; Poblenz, A; Starbuck, MW; Thompson, JT1
Anderson, P; Dawra, N; Emara, MM; Hickman, T; Hu, GF; Ivanov, P; Kedersha, N; Tisdale, S1
Bi, Y; Chen, L; Gao, JL; Gao, Y; Haydon, RC; He, BC; He, TC; Hu, N; Huang, E; Jiang, W; Kim, SH; Li, M; Liu, X; Luo, J; Luo, Q; Luo, X; Luther, G; Luu, HH; Rastegar, F; Shen, J; Shenaq, D; Shi, Q; Wagner, ER; Wang, L; Yang, K; Zuo, GW1
Feng, YM; Guo, S; Li, N; Liu, LL; Min, J; Su, HC; Zhang, HL; Zhang, JP1
Agrawal, S; Araujo, JC; Armstrong, AJ; Braud, EL; Gallick, GE; Logothetis, CJ; Lonberg, M; Mathew, P; Paliwal, P; Posadas, E; Trudel, GC1
Anderson, HC; Garimella, R; Keighley, J; Pinson, D; Tancabelic, J; Tawfik, O; Templeton, K; Thompson, L; Wang, S1
Agarwal, N; Sonpavde, G; Sternberg, CN1
Chan, CM; Haugen, BR; Jing, X; Lim, DJ; Lund, GS; Pike, LA; Sams, SB; Schweppe, RE; Sharma, V; Zhou, Q1
Gleave, ME; Loriot, Y; Zoubeidi, A1
Ardito, R; De Santis, V; Falcone, G; Maccauro, G; Muratori, F; Rosa, MA; Sgambato, A1
Egerbacher, M; Hoelzl, C; Thalhammer, JG; Walter, I; Wolfesberger, B1
Hosono, K; Ishiguro, N; Naruse, T; Nishida, Y1
Egerbacher, M; Fertl, G; Hoelzl, C; Reider, GA; Skalicky, M; Thalhammer, JG; Walter, I; Wolfesberger, B1
Isoe, T; Kobayashi, Y; Kubo, K; Murooka, H; Nishitoba, T; Ohno, H; Shibuya, M; Yoneda, T1
Jove, R; Keschman, EA; Lee, FY; Letson, GD; Muro-Cacho, C; Pledger, WJ; Shor, AC; Trent, JC1
Cordero di Montezemolo, L; Crescenzio, N; Doria, A; Fandi, A; Foglia, L; Timeus, F1
Morishita, H; Tanaka, M; Tomita, K; Tsuchiya, H; Ueda, Y1
Benassi, MS; Ferrari, C; Gamberi, G; Magagnoli, G; Maltarello, MC; Merli, M; Molendini, L; Picci, P; Ragazzini, P; Sollazzo, MR1
Alessandra Gobbi, G; Lattanzi, G; Lucarelli, E; Maini, V; Marmiroli, S; Mordenti, M; Picci, P; Reggiani, M; Sangiorgi, L; Scrimieri, F; Zambon Bertoja, A1
Inoue, H; Ito, S; Kawai, A; Ozaki, T; Sato, J; Tanabe, G1

Reviews

5 review(s) available for thiazoles and Bone Cancer

ArticleYear
Targeting mast cells in gastric cancer with special reference to bone metastases.
    World journal of gastroenterology, 2015, Oct-07, Volume: 21, Issue:37

    Topics: Animals; Antigens, CD34; Benzamides; Benzamidines; Bone and Bones; Bone Neoplasms; Bone Resorption; Disease Progression; Gabexate; Guanidines; Humans; Imatinib Mesylate; Immune System; Mast Cells; Neovascularization, Pathologic; NF-kappa B; Piperidines; Proto-Oncogene Proteins c-kit; Pyridines; Stomach Neoplasms; Thiazoles; Tryptases

2015
Cathepsin K inhibitors as treatment of bone metastasis.
    Current opinion in supportive and palliative care, 2008, Volume: 2, Issue:3

    Topics: Azepines; Benzamides; Biphenyl Compounds; Bone Neoplasms; Bone Remodeling; Bone Resorption; Breast Neoplasms; Cathepsin K; Cathepsins; Female; Humans; Male; Osteoclasts; Piperazines; Prostatic Neoplasms; Sulfones; Thiazoles

2008
Src as a therapeutic target in men with prostate cancer and bone metastases.
    BJU international, 2009, Volume: 103, Issue:4

    Topics: Antineoplastic Agents; Benzodioxoles; Bone Neoplasms; Dasatinib; Humans; Male; Prostatic Neoplasms; Protein Kinase Inhibitors; Proto-Oncogene Mas; Pyrimidines; Quinazolines; Receptors, Androgen; src-Family Kinases; Thiazoles

2009
Novel molecular targets for the therapy of castration-resistant prostate cancer.
    European urology, 2012, Volume: 61, Issue:5

    Topics: Abiraterone Acetate; Androstadienes; Anilides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzamides; Bone Neoplasms; Cancer Vaccines; Carcinoma; Clinical Trials, Phase III as Topic; Clusterin; Dasatinib; Denosumab; Humans; Ipilimumab; Male; Nitriles; Orchiectomy; Phenylthiohydantoin; Prostatic Neoplasms; Pyridines; Pyrimidines; Quinolines; Quinolones; Radium; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Taxoids; Thiazoles; Tissue Extracts; Treatment Outcome; Vaccines, Synthetic

2012
Targeted therapies in metastatic castration-resistant prostate cancer: beyond the androgen receptor.
    The Urologic clinics of North America, 2012, Volume: 39, Issue:4

    Topics: Bone Neoplasms; Cell Proliferation; Cell Survival; Dasatinib; Disease Progression; DNA Repair; Epothilones; Gene Fusion; Humans; Male; Neoplasm Invasiveness; Prostatic Neoplasms; Proto-Oncogene Proteins c-met; Pyrimidines; Receptors, Androgen; Taxoids; Thiazoles

2012

Trials

2 trial(s) available for thiazoles and Bone Cancer

ArticleYear
Castration-resistant prostate cancer bone metastasis response measured by 18F-fluoride PET after treatment with dasatinib and correlation with progression-free survival: results from American College of Radiology Imaging Network 6687.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015, Volume: 56, Issue:3

    Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Biopsy; Bone and Bones; Bone Neoplasms; Dasatinib; Disease-Free Survival; Fluorine Radioisotopes; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Prostatic Neoplasms, Castration-Resistant; Protein Kinase Inhibitors; Pyrimidines; Receptors, Androgen; Thiazoles; Tomography, X-Ray Computed; Treatment Outcome

2015
Dasatinib combined with docetaxel for castration-resistant prostate cancer: results from a phase 1-2 study.
    Cancer, 2012, Jan-01, Volume: 118, Issue:1

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Castration; Dasatinib; Docetaxel; Drug Administration Schedule; Humans; Male; Maximum Tolerated Dose; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Pyrimidines; Taxoids; Thiazoles

2012

Other Studies

36 other study(ies) available for thiazoles and Bone Cancer

ArticleYear
Inhibition of the Notch signaling pathway attenuates progression of cell motility, metastasis, and epithelial-to-mesenchymal transition-like phenomena induced by low concentrations of cisplatin in osteosarcoma.
    European journal of pharmacology, 2021, May-15, Volume: 899

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cisplatin; Diamines; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Osteosarcoma; Receptors, Notch; Signal Transduction; Thiazoles; Xenograft Model Antitumor Assays

2021
The smac mimetic LCL161 targets established pulmonary osteosarcoma metastases in mice.
    Clinical & experimental metastasis, 2021, Volume: 38, Issue:5

    Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Cell Line, Tumor; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Osteosarcoma; Thiazoles; Xenograft Model Antitumor Assays

2021
Development of a novel bioactive glass suitable for osteosarcoma-related bone grafts.
    Journal of biomedical materials research. Part B, Applied biomaterials, 2018, Volume: 106, Issue:3

    Topics: Bone Neoplasms; Bone Substitutes; Borates; Cell Line, Tumor; Cell Proliferation; Gallium; Glass; Humans; Osteoblasts; Osteosarcoma; Powders; Tetrazolium Salts; Thiazoles; Zinc Compounds

2018
Notch pathway inhibition using DAPT, a γ-secretase inhibitor (GSI), enhances the antitumor effect of cisplatin in resistant osteosarcoma.
    Molecular carcinogenesis, 2019, Volume: 58, Issue:1

    Topics: Adolescent; Adult; Amyloid Precursor Protein Secretases; Animals; Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Bone Neoplasms; Case-Control Studies; Cell Proliferation; Child; Cisplatin; Diamines; Drug Resistance, Neoplasm; Drug Synergism; Drug Therapy, Combination; Follow-Up Studies; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplastic Stem Cells; Osteosarcoma; Prognosis; Receptor, Notch1; Signal Transduction; Survival Rate; Thiazoles; Tumor Cells, Cultured; Xenograft Model Antitumor Assays; Young Adult

2019
Oestrogen-related receptor alpha mediates chemotherapy resistance of osteosarcoma cells via regulation of ABCB1.
    Journal of cellular and molecular medicine, 2019, Volume: 23, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Cisplatin; Doxorubicin; Drug Resistance, Neoplasm; ERRalpha Estrogen-Related Receptor; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Nitriles; Osteosarcoma; Protein Binding; Receptors, Estrogen; RNA Interference; Sp3 Transcription Factor; Thiazoles

2019
Apoptotic effects of the tyrosine kinase inhibitor, masitinib mesylate, on canine osteosarcoma cells.
    Anti-cancer drugs, 2013, Volume: 24, Issue:5

    Topics: Animals; Antineoplastic Agents; Apoptosis; Benzamides; Bone Neoplasms; Cell Line, Tumor; Cell Survival; Dogs; Dose-Response Relationship, Drug; Osteosarcoma; Piperidines; Protein Kinase Inhibitors; Pyridines; Thiazoles; Vascular Endothelial Growth Factor A

2013
A case study of personalized therapy for osteosarcoma.
    Pediatric blood & cancer, 2013, Volume: 60, Issue:8

    Topics: Animals; Bone Neoplasms; Cell Line, Tumor; Dasatinib; Dog Diseases; Dogs; Osteosarcoma; Protein Kinase Inhibitors; Pyrimidines; Radiography; src-Family Kinases; Thiazoles; Time Factors

2013
Combined zoledronic acid and meloxicam reduced bone loss and tumour growth in an orthotopic mouse model of bone-invasive oral squamous cell carcinoma.
    Veterinary and comparative oncology, 2015, Volume: 13, Issue:3

    Topics: Analysis of Variance; Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Bone Neoplasms; Bone Resorption; Cat Diseases; Cats; Cell Line, Tumor; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Diphosphonates; Disease Models, Animal; Heterografts; Humans; Imidazoles; Male; Meloxicam; Mice; Mice, Nude; Mouth Neoplasms; Neoplasms, Squamous Cell; Random Allocation; Real-Time Polymerase Chain Reaction; RNA, Messenger; Thiazines; Thiazoles; Treatment Outcome; Zoledronic Acid

2015
Src kinases in chondrosarcoma chemoresistance and migration: dasatinib sensitises to doxorubicin in TP53 mutant cells.
    British journal of cancer, 2013, Sep-03, Volume: 109, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Chondrosarcoma; Dasatinib; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Female; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; HeLa Cells; Humans; Indoles; Male; MCF-7 Cells; Middle Aged; Mutation; Phosphatidylinositol 3-Kinases; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-fyn; Pyrimidines; Signal Transduction; src-Family Kinases; Thiazoles; Tumor Suppressor Protein p53; Young Adult

2013
BYL719, a new α-specific PI3K inhibitor: single administration and in combination with conventional chemotherapy for the treatment of osteosarcoma.
    International journal of cancer, 2015, Feb-15, Volume: 136, Issue:4

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cell Line, Tumor; Drug Synergism; Female; Humans; Inhibitory Concentration 50; Male; Mice, Inbred C57BL; Mice, Nude; Osteoblasts; Osteoclasts; Osteosarcoma; Phosphoinositide-3 Kinase Inhibitors; Thiazoles; Tumor Burden; Xenograft Model Antitumor Assays

2015
Primary tumour growth in an orthotopic osteosarcoma mouse model is not influenced by analgesic treatment with buprenorphine and meloxicam.
    Laboratory animals, 2015, Volume: 49, Issue:4

    Topics: Analgesics, Opioid; Animal Welfare; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bone Neoplasms; Buprenorphine; Disease Models, Animal; Drug Therapy, Combination; Female; Injections; Longevity; Lung Neoplasms; Meloxicam; Mice; Mice, SCID; Osteosarcoma; Pain Management; Thiazines; Thiazoles; Tibia

2015
Potential antiproliferative effect of isoxazolo- and thiazolo coumarin derivatives on breast cancer mediated bone and lung metastases.
    Acta pharmaceutica (Zagreb, Croatia), 2015, Volume: 65, Issue:1

    Topics: 4-Hydroxycoumarins; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Coumarins; Dose-Response Relationship, Drug; Female; Humans; Inhibitory Concentration 50; Isoxazoles; Lung Neoplasms; Thiazoles; Time Factors

2015
RETRA exerts anticancer activity in Ewing's sarcoma cells independent of their TP53 status.
    European journal of cancer (Oxford, England : 1990), 2015, Volume: 51, Issue:7

    Topics: Antineoplastic Agents; Bone Neoplasms; Catechols; Cell Cycle Checkpoints; Cell Proliferation; HCT116 Cells; Humans; Mutation; Sarcoma, Ewing; Thiazoles; Tumor Cells, Cultured; Tumor Suppressor Protein p53

2015
Discovery of DS-5272 as a promising candidate: A potent and orally active p53-MDM2 interaction inhibitor.
    Bioorganic & medicinal chemistry, 2015, May-15, Volume: 23, Issue:10

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Discovery; Fluorine; Gene Expression; Humans; Imidazoles; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Protein Binding; Proto-Oncogene Proteins c-mdm2; Pyrrolidines; Sarcoma; Thiazoles; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays

2015
BMI1 is expressed in canine osteosarcoma and contributes to cell growth and chemotherapy resistance.
    PloS one, 2015, Volume: 10, Issue:6

    Topics: Adolescent; Animals; Antineoplastic Agents; Bone Neoplasms; Carboplatin; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Dogs; Doxorubicin; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds, 2-Ring; Humans; Male; Osteosarcoma; Polycomb Repressive Complex 1; Thiazoles

2015
Utilizing the protein corona around silica nanoparticles for dual drug loading and release.
    Nanoscale, 2015, Oct-21, Volume: 7, Issue:39

    Topics: Blood Proteins; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Doxorubicin; Drug Carriers; Humans; Meloxicam; Nanoparticles; Osteosarcoma; Silicon Dioxide; Thiazines; Thiazoles

2015
IAP antagonists sensitize murine osteosarcoma cells to killing by TNFα.
    Oncotarget, 2016, Jun-07, Volume: 7, Issue:23

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Baculoviral IAP Repeat-Containing 3 Protein; Bone Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cell Survival; Cyclohexanes; Dose-Response Relationship, Drug; Genetic Predisposition to Disease; HEK293 Cells; Humans; Inhibitor of Apoptosis Proteins; Mice, Knockout; Osteosarcoma; Phenotype; Pyrroles; Receptor-Interacting Protein Serine-Threonine Kinases; Retinoblastoma Protein; Signal Transduction; Thiazoles; TNF-Related Apoptosis-Inducing Ligand; Transfection; Triazoles; Tumor Necrosis Factor-alpha; Tumor Suppressor Protein p53; Ubiquitin-Protein Ligases

2016
Dasatinib inhibits the growth of prostate cancer in bone and provides additional protection from osteolysis.
    British journal of cancer, 2009, Jul-21, Volume: 101, Issue:2

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Density; Bone Neoplasms; Cell Line, Tumor; Dasatinib; Docetaxel; Humans; Male; Mice; Mice, SCID; Osteolysis; Prostate-Specific Antigen; Prostatic Neoplasms; Protein Kinase Inhibitors; Pyrimidines; src-Family Kinases; Taxoids; Thiazoles; Xenograft Model Antitumor Assays

2009
[MTT assay for detecting osteosarcoma cell apoptosis].
    Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2009, Volume: 29, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bone Neoplasms; Humans; Osteosarcoma; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured

2009
Dasatinib inhibits both osteoclast activation and prostate cancer PC-3-cell-induced osteoclast formation.
    Cancer biology & therapy, 2009, Volume: 8, Issue:22

    Topics: Adenocarcinoma; Animals; Bone Marrow Cells; Bone Neoplasms; Cell Differentiation; Cell Line, Tumor; Collagen; Dasatinib; Humans; Male; Mice; Mice, Inbred C57BL; Monocytes; Neoplasm Proteins; Osteoclasts; Prostatic Neoplasms; Protein Kinase Inhibitors; Pyrimidines; RANK Ligand; src-Family Kinases; Thiazoles

2009
Angiogenin-induced tRNA-derived stress-induced RNAs promote stress-induced stress granule assembly.
    The Journal of biological chemistry, 2010, Apr-02, Volume: 285, Issue:14

    Topics: Arsenites; Blotting, Western; Bone Neoplasms; Carrier Proteins; Cells, Cultured; Cytoplasmic Granules; Enzyme Inhibitors; Epoxy Compounds; Eukaryotic Initiation Factor-2; Fluorescent Antibody Technique; Humans; Macrolides; Osteosarcoma; Oxidative Stress; Phosphorylation; Protein Biosynthesis; Reverse Transcriptase Polymerase Chain Reaction; Ribonuclease, Pancreatic; RNA, Messenger; RNA, Small Interfering; RNA, Transfer; Teratogens; Thiazoles; Tumor Cells, Cultured

2010
Lysophosphatidic acid acyltransferase β (LPAATβ) promotes the tumor growth of human osteosarcoma.
    PloS one, 2010, Dec-01, Volume: 5, Issue:12

    Topics: Acyltransferases; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Progression; Gene Expression Regulation, Neoplastic; Gentian Violet; Humans; Lipids; Neoplasm Metastasis; Osteosarcoma; Phenotype; Reverse Transcriptase Polymerase Chain Reaction; Tetrazolium Salts; Thiazoles

2010
Down-regulation of β3-integrin inhibits bone metastasis of small cell lung cancer.
    Molecular biology reports, 2012, Volume: 39, Issue:3

    Topics: Apoptosis; Blotting, Western; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Collagen; Colony-Forming Units Assay; Drug Combinations; Flow Cytometry; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; Humans; Integrin beta3; Laminin; Proteoglycans; Real-Time Polymerase Chain Reaction; RNA, Small Interfering; Small Cell Lung Carcinoma; Tetrazolium Salts; Thiazoles

2012
Effect of 25-hydroxyvitamin D3 and 1 α,25 dihydroxyvitamin D3 on differentiation and apoptosis of human osteosarcoma cell lines.
    Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 2012, Volume: 30, Issue:5

    Topics: Alkaline Phosphatase; Apoptosis; Bone Density Conservation Agents; Bone Neoplasms; Calcifediol; Calcitriol; Cell Cycle; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Ki-67 Antigen; Osteocalcin; Osteosarcoma; Pilot Projects; Receptors, Calcitriol; Retinoblastoma Protein; RNA, Messenger; Tetrazolium Salts; Thiazoles; Tumor Suppressor Protein p53

2012
Targeted inhibition of Src kinase with dasatinib blocks thyroid cancer growth and metastasis.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2012, Jul-01, Volume: 18, Issue:13

    Topics: Animals; Antineoplastic Agents; Apoptosis; Bone Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dasatinib; Focal Adhesion Kinase 1; Humans; Male; Mice; Mice, Nude; Phosphorylation; Protein Processing, Post-Translational; Pyrimidines; Signal Transduction; src-Family Kinases; Thiazoles; Thyroid Neoplasms; Tumor Burden; Xenograft Model Antitumor Assays

2012
Acrylic cement added with antiblastics in the treatment of bone metastases. Ultrastructural and in vitro analysis.
    The Journal of bone and joint surgery. British volume, 2003, Volume: 85, Issue:5

    Topics: Antineoplastic Agents; Bone Cements; Bone Neoplasms; Cell Division; Cell Survival; Cisplatin; Coloring Agents; Doxorubicin; Drug Carriers; Humans; Methotrexate; Methylmethacrylate; Microscopy, Electron, Scanning; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured

2003
Antineoplastic effect of the cyclooxygenase inhibitor meloxicam on canine osteosarcoma cells.
    Research in veterinary science, 2006, Volume: 80, Issue:3

    Topics: Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Bone Neoplasms; Caspase 3; Caspases; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dog Diseases; Dogs; Immunohistochemistry; Meloxicam; Microscopy, Electron, Transmission; Microscopy, Fluorescence; Osteosarcoma; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Thiazines; Thiazoles

2006
Meloxicam inhibits osteosarcoma growth, invasiveness and metastasis by COX-2-dependent and independent routes.
    Carcinogenesis, 2006, Volume: 27, Issue:3

    Topics: Apoptosis; Blotting, Western; Bone Neoplasms; Cell Proliferation; Cell Survival; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprostone; Gene Expression Profiling; Humans; Meloxicam; Osteosarcoma; Reverse Transcriptase Polymerase Chain Reaction; Thiazines; Thiazoles; Tumor Cells, Cultured

2006
In vitro effects of meloxicam with or without doxorubicin on canine osteosarcoma cells.
    Journal of veterinary pharmacology and therapeutics, 2006, Volume: 29, Issue:1

    Topics: Animals; Antibiotics, Antineoplastic; Bone Neoplasms; Cyclooxygenase Inhibitors; Dogs; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Meloxicam; Osteosarcoma; Thiazines; Thiazoles; Tumor Cells, Cultured

2006
A c-fms tyrosine kinase inhibitor, Ki20227, suppresses osteoclast differentiation and osteolytic bone destruction in a bone metastasis model.
    Molecular cancer therapeutics, 2006, Volume: 5, Issue:11

    Topics: Acid Phosphatase; Animals; Bone Neoplasms; Cell Differentiation; Cell Line, Tumor; Dose-Response Relationship, Drug; Humans; Isoenzymes; Mice; Mice, Transgenic; Osteoclasts; Osteolysis; Phenylurea Compounds; Protein Kinase Inhibitors; Proto-Oncogene Mas; Rats; Rats, Inbred F344; Rats, Nude; Receptor, Macrophage Colony-Stimulating Factor; Tartrate-Resistant Acid Phosphatase; Thiazoles

2006
Dasatinib inhibits migration and invasion in diverse human sarcoma cell lines and induces apoptosis in bone sarcoma cells dependent on SRC kinase for survival.
    Cancer research, 2007, Mar-15, Volume: 67, Issue:6

    Topics: Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Dasatinib; Enzyme Activation; Humans; Neoplasm Invasiveness; Osteosarcoma; Protein Kinase Inhibitors; Pyrimidines; Rhabdomyosarcoma; Sarcoma, Ewing; Signal Transduction; src-Family Kinases; Thiazoles

2007
In vitro antiproliferative and antimigratory activity of dasatinib in neuroblastoma and Ewing sarcoma cell lines.
    Oncology reports, 2008, Volume: 19, Issue:2

    Topics: Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dasatinib; Humans; Neuroblastoma; Protein Kinase Inhibitors; Pyrimidines; Sarcoma, Ewing; Thiazoles

2008
Differentiating and antitumor activities of 1 alpha,25-dihydroxyvitamin D3 in vitro and 1 alpha-hydroxyvitamin D3 in vivo on human osteosarcoma.
    Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 1993, Volume: 11, Issue:1

    Topics: Adolescent; Alkaline Phosphatase; Animals; Antineoplastic Agents; Bone Neoplasms; Calcitriol; Cell Transformation, Neoplastic; Cisplatin; Culture Media; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hydroxycholecalciferols; Mice; Mice, Nude; Osteocalcin; Osteosarcoma; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured

1993
Expression of G1 phase regulators in MG-63 osteosarcoma cell line.
    International journal of oncology, 1999, Volume: 14, Issue:6

    Topics: Apoptosis; Bone Neoplasms; CDC2-CDC28 Kinases; Cell Cycle Proteins; Cell Division; Cyclin D1; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Cyclins; G1 Phase; Humans; Interleukin-6; Osteosarcoma; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Retinoblastoma Protein; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha

1999
Troglitazione affects survival of human osteosarcoma cells.
    International journal of cancer, 2002, Mar-20, Volume: 98, Issue:3

    Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Bone Neoplasms; Cell Count; Cell Division; Cell Survival; Chromans; Humans; Osteosarcoma; Precipitin Tests; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone; Tumor Cells, Cultured

2002
[A study of MTT-hybrid assay using human bone and soft tissue tumor cells].
    Human cell, 1989, Volume: 2, Issue:3

    Topics: Antineoplastic Agents; Bone Neoplasms; Drug Screening Assays, Antitumor; Humans; Soft Tissue Neoplasms; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured; Tumor Stem Cell Assay

1989